INTELLIGENT BIO SOLUTIONS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.88 million shares for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-02-11
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 14.88M shares, a 72.60% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 14.01M shares, a 62.30% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 12.66M shares, a 48.73% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 11.80M shares, a 38.61% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 10.41M shares, a 22.38% increase from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 8.51M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 14.88M shares 10-Q · filed 2022-02-11 | 14.44M shares 10-Q · filed 2022-02-11 | 13.85M shares derived: average of 3 quarters · filed 2022-02-11 | 13.34M shares derived: average of 4 quarters · filed 2022-02-11 |
| 2021-09-30 | 14.01M shares 10-Q · filed 2021-11-12 | 13.33M shares derived: average of 2 quarters · filed 2021-11-12 | 12.82M shares derived: average of 3 quarters · filed 2021-11-12 | 11.77M shares derived: average of 4 quarters · filed 2022-02-11 |
| 2021-06-30 | 12.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | 12.23M shares derived: average of 2 quarters · filed 2021-09-16 | 11.03M shares derived: average of 3 quarters · filed 2022-02-11 | 10.41M shares 10-K · filed 2021-09-16 |
| 2021-03-31 | 11.80M shares 10-Q · filed 2021-05-13 | 10.21M shares derived: average of 2 quarters · filed 2022-02-11 | 9.67M shares 10-Q · filed 2021-05-13 | 9.39M shares derived: average of 4 quarters · filed 2022-02-11 |
| 2020-12-31 | 8.62M shares 10-Q · filed 2022-02-11 | 8.63M shares 10-Q · filed 2022-02-11 | 8.59M shares derived: average of 3 quarters · filed 2022-02-11 | 8.57M shares derived: average of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | 8.63M shares 10-Q · filed 2021-11-12 | 8.57M shares derived: average of 2 quarters · filed 2021-11-12 | 8.55M shares derived: average of 3 quarters · filed 2021-11-12 | 8.54M shares derived: average of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | 8.51M shares 10-Q · filed 2021-02-12 | 8.51M shares 10-Q · filed 2021-02-12 | 8.51M shares derived: average of 3 quarters · filed 2021-05-13 | 8.51M shares 10-K · filed 2021-09-16 |
| 2020-03-31 | 8.51M shares 10-Q · filed 2021-05-13 | 8.51M shares derived: average of 2 quarters · filed 2021-05-13 | 8.51M shares 10-Q · filed 2021-05-13 | |
| 2019-12-31 | 8.51M shares 10-Q · filed 2021-02-12 | 8.51M shares 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |